Skip to content
Open Access Published by De Gruyter August 10, 2005

Anaphylatoxins in preterm and term labor

  • Eleazar Soto , Roberto Romero , Karina Richani , Jimmy Espinoza , Jyh Kae Nien , Tinnakorn Chaiworapongsa , Joaquin Santolaya-Forgas , Samuel S. Edwin and Moshe Mazor

Abstract

Objective: The complement system plays a central role in the first line of defense against invading pathogens, and its activation involves the release of potent pro-inflammatory mediators such as anaphylatoxins C3a, C4a and C5a. The aim of this study was to determine whether differences existed in maternal plasma anaphylatoxin concentrations between patients with term and preterm parturition.

Study design: A cross-sectional study was designed to determine the plasma anaphylatoxin concentrations in 296 pregnant women in the following groups: 1) normal pregnancy between 20–36 6/7 weeks (n=64); 2) term not in labor (n=70); 3) term in labor (n=60); and 4) preterm labor with intact membranes (n=102). Women with preterm labor were classified into: a) term delivery (n=24); b) preterm delivery without intra-amniotic infection (IAI) (n=62); and c) preterm delivery with IAI (n=16). Concentrations of C3a, C4a and C5a were determined by ELISAs. Statistical analysis was conducted with non-parametric methods.

Results: 1) The median plasma C5a concentration was lower in women at term in labor than in those not in labor (P<0.001). In contrast, there were no differences in plasma C3a and C4a concentrations between the two groups (P>0.05). 2) Among patients with preterm labor, those with IAI had a higher median plasma C5a concentration than those without IAI and those who delivered at term (post-hoc tests P<0.001 and P=0.01, respectively). When comparing the preterm labor subgroups with normal pregnancy, only women with preterm delivery and IAI had a median plasma C5a concentration higher than that of normal pregnant women (Kruskal-Wallis P<0.001, post hoc test P<0.001). There was no difference in the plasma C4a concentration among patients with preterm labor. The median plasma C3a concentration in patients with preterm labor with IAI was higher than in those without IAI (Kruskal-Wallis P=0.01, and post-hoc test P=0.005). There was no difference in the plasma C3a concentrations between women with preterm labor who delivered at term and those with preterm delivery, with or without IAI. In addition, no differences were observed in the median plasma C3a concentration between women with normal pregnancy and those in each of the preterm labor subgroups.

Conclusions: The maternal plasma concentration of anaphylatoxin C5a is increased in women with preterm labor and IAI, but not in spontaneous labor at term.

:

Corresponding author: Roberto Romero, MD Chief, Perinatology Research Branch, NICHD, NIH, DHHS, Hutzel Women's Hospital, 3990 John R, 4th Floor Detroit, MI 48201, USA,

References

1 Ahmed AE, JB Peter: Clinical utility of complement assessment. Clin Diagn Lab Immunol2 (1995) 509Search in Google Scholar

2 Albrecht EA, AM Chinnaiyan, S Varambally, C Kumar-Sinha, TR Barrette, JV Sarma, PA Ward: C5a-induced gene expression in human umbilical vein endothelial cells. Am J Pathol164 (2004) 849Search in Google Scholar

3 Alexander GR, JH Himes, RB Kaufman, J Mor, M Kogan: A United States national reference for fetal growth. Obstet Gynecol87 (1996) 163Search in Google Scholar

4 Amon E: Preterm Labor. In: Reece E, Hobbins J: Medicine of the Fetus and Mother. Lippincontt-Robin, Philladelphia 1999Search in Google Scholar

5 Carroll MC: The complement system in regulation of adaptive immunity. Nat Immunol5 (2004) 98110.1038/ni1113Search in Google Scholar

6 Cochrane CG, HJ Muller-Eberhard: The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J Exp Med127 (1968) 371Search in Google Scholar

7 Czermak BJ, V Sarma, CL Pierson, RL Warner, M Huber-Lang, NM Bless, H Schmal, HP Friedl, PA Ward: Protective effects of C5a blockade in sepsis. Nat Med5 (1999) 788Search in Google Scholar

8 Daffern PJ, PH Pfeifer, JA Ember, TE Hugli: C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med181 (1995) 2119Search in Google Scholar

9 Dias DS, IH Lepow: Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement. J Exp Med125 (1967) 921Search in Google Scholar

10 Ehrengruber MU, T Geiser, DA Deranleau: Activation of human neutrophils by C3a and C5A. Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst. FEBS Lett346 (1994) 181Search in Google Scholar

11 Ember JA, MA Jagels, TE Hugli: Characterization of Complement Anaphylatoxins and Their Biological Responses. In: Volanakis JE, Frank MM: The Human Complement System in Health and Disease. Marcel Dekker, INC., New York 199810.1201/b14212-12Search in Google Scholar

12 Ember JA, SD Sanderson, TE Hugli, EL Morgan: Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am J Pathol144 (1994) 393Search in Google Scholar

13 Foreman KE, AA Vaporciyan, BK Bonish, ML Jones, KJ Johnson, MM Glovsky, SM Eddy, PA Ward: C5a-induced expression of P-selectin in endothelial cells. J Clin Invest94 (1994) 1147Search in Google Scholar

14 Foulder-Hughes LA, RWI Cooke: Motor, cognitive, and behavioural disorders in children born very preterm. Developmental Medicine and Child Neurology45 (2003) 9710.1111/j.1469-8749.2003.tb00912.xSearch in Google Scholar

15 Gasque P: Complement: a unique innate immune sensor for danger signals. Mol Immunol41 (2004) 108910.1016/j.molimm.2004.06.011Search in Google Scholar

16 Gervasi MT, T Chaiworapongsa, N Naccasha, S Blackwell, BH Yoon, E Maymon, R Romero: Phenotypic and metabolic characteristics of maternal monocytes and granulocytes in preterm labor with intact membranes. Am J Obstet Gynecol185 (2001) 1124Search in Google Scholar

17 Gervasi MT, T Chaiworapongsa, N Naccasha, P Pacora, S Berman, E Maymon, JC Kim, YM Kim, J Yoshimatsu, J Espinoza, R Romero: Maternal intravascular inflammation in preterm premature rupture of membranes. J Matern Fetal Neonatal Med11 (2002) 171Search in Google Scholar

18 Girardi G, J Berman, P Redecha, L Spruce, JM Thurman, D Kraus, TJ Hollmann, P Casali, MC Caroll, RA Wetsel, JD Lambris, VM Holers, JE Salmon: Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest112 (2003) 1644Search in Google Scholar

19 Goldstein IM, D Roos, HB Kaplan, G Weissmann: Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis. J Clin Invest56 (1975) 1155Search in Google Scholar

20 Gomez R, F Ghezzi, R Romero, H Munoz, JE Tolosa, I Rojas: Premature labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology. Clin Perinatol22 (1995) 281Search in Google Scholar

21 Gorski JP, TE Hugli, HJ Muller-Eberhard: C4a: the third anaphylatoxin of the human complement system. Proc Natl Acad Sci USA76 (1979) 5299Search in Google Scholar

22 Grant EP, D Picarella, T Burwell, T Delaney, A Croci, N Avitahl, AA Humbles, JC Gutierrez-Ramos, M Briskin, C Gerard, AJ Coyle: Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis. J Exp Med196 (2002) 1461Search in Google Scholar

23 Haeger M, M Unander, B Norder-Hansson, M Tylman, A Bengtsson: Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol79 (1992) 19Search in Google Scholar

24 Hartmann K, BM Henz, S Kruger-Krasagakes, J Kohl, R Burger, S Guhl, I Haase, U Lippert, T Zuberbier: C3a and C5a stimulate chemotaxis of human mast cells. Blood89 (1997) 2863Search in Google Scholar

25 Hebisch G, PM Neumaier-Wagner, R Huch, U von Mandach: Maternal serum interleukin-1 beta, -6 and -8 levels and potential determinants in pregnancy and peripartum. J Perinat Med32 (2004) 475Search in Google Scholar

26 Huber-Lang M, EM Younkin, JV Sarma, N Riedemann, SR McGuire, KT Lu, R Kunkel, JG Younger, FS Zetoune, PA Ward: Generation of C5a by phagocytic cells. Am J Pathol161 (2002) 1849Search in Google Scholar

27 Huffaker J, SS Witkin, L Cutler, ML Druzin, WJ Ledger: Total complement activity in maternal sera, amniotic fluids and cord sera in women with premature labor, premature rupture of membranes or chorioamnionitis. Surg Gynecol Obstet168 (1989) 397Search in Google Scholar

28 Humbles AA, B Lu, CA Nilsson, C Lilly, E Israel, Y Fujiwara, NP Gerard, C Gerard: A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature406 (2000) 998Search in Google Scholar

29 Jagels MA, PJ Daffern, TE Hugli: C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion. Immunopharmacology46 (2000) 209Search in Google Scholar

30 Keelan JA, M Blumenstein, RJ Helliwell, TA Sato, KW Marvin, MD Mitchell: Cytokines, prostaglandins and parturition–a review. Placenta24Suppl A (2003) S3310.1053/plac.2002.0948Search in Google Scholar

31 Kelly RW: Inflammatory mediators and parturition. Rev Reprod1 (1996) 8910.1530/ror.0.0010089Search in Google Scholar

32 Kovar IZ, PG Riches: C3 and C4 complement components and acute phase proteins in late pregnancy and parturition. J Clin Pathol41 (1988) 650Search in Google Scholar

33 Mathews TJ, F Menacker, MF MacDorman: Infant mortality statistics from the 2002 period: linked birth/infant death data set. Natl Vital Stat Rep53 (2004) 1Search in Google Scholar

34 Medzhitov R, CA Janeway, Jr.: Decoding the patterns of self and nonself by the innate immune system. Science296 (2002) 298Search in Google Scholar

35 Moxley G, S Ruddy: Elevated plasma C3 anaphylatoxin levels in rheumatoid arthritis patients. Arthritis Rheum30 (1987) 1097Search in Google Scholar

36 Nakae H, S Endo, K Inada, M Yoshida: Chronological changes in the complement system in sepsis. Surg Today26 (1996) 225Search in Google Scholar

37 Nakano Y, S Morita, A Kawamoto, T Suda, K Chida, H Nakamura: Elevated complement C3a in plasma from patients with severe acute asthma. J Allergy Clin Immunol112 (2003) 525Search in Google Scholar

38 Okusawa S, CA Dinarello, KB Yancey, S Endres, TJ Lawley, MM Frank, JF Burke, JA Gelfand: C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma. J Immunol139 (1987) 2635Search in Google Scholar

39 Okusawa S, KB Yancey, JW van der Meer, S Endres, G Lonnemann, K Hefter, MM Frank, JF Burke, CA Dinarello, JA Gelfand: C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha. J Exp Med168 (1988) 443Search in Google Scholar

40 Perianayagam MC, VS Balakrishnan, AJ King, BJ Pereira, BL Jaber: C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway. Kidney Int61 (2002) 456Search in Google Scholar

41 Richani K, E Soto, J Espinoza, J Nien, T Chaiworapongsa, S Edwin, M Mazor, R Romero: Normal pregnancy is characterized by systemic complement activation of the complement system. Am J Obstet Gynecol191 (2004) S139 (abstract)10.1016/j.ajog.2004.10.389Search in Google Scholar

42 Riedemann NC, RF Guo, TJ Hollmann, H Gao, TA Neff, JS Reuben, CL Speyer, JV Sarma, RA Wetsel, FS Zetoune, PA Ward: Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J18 (2004) 370Search in Google Scholar

43 Romero R, J Espinoza, M Mazor, T Chaiworapongsa: The preterm parturition syndrome. In: Critchley C, Bennet P, Thornton S: Preterm Birth. RCOG Press, London 2004Search in Google Scholar

44 Schindler R, JA Gelfand, CA Dinarello: Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself. Blood76 (1990) 1631Search in Google Scholar

45 Scholz W, MR McClurg, GJ Cardenas, M Smith, DJ Noonan, TE Hugli, EL Morgan: C5a-mediated release of interleukin 6 by human monocytes. Clin Immunol Immunopathol57 (1990) 297Search in Google Scholar

46 Schumacher WA, JC Fantone, SE Kunkel, RC Webb, BR Lucchesi: The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculature in vitro and in vivo. Agents Actions34 (1991) 345Search in Google Scholar

47 Shin HS, R Snyderman, E Friedman, A Mellors, MM Mayer: Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement. Science162 (1968) 361Search in Google Scholar

48 Siegel I, N Gleicher: Peripheral white blood cell alterations in early labor. Diagn Gynecol Obstet3 (1981) 123Search in Google Scholar

49 Slattery MM, JJ Morrison: Preterm delivery. Lancet360 (2002) 1489Search in Google Scholar

50 Stevens JH, P O'Hanley, JM Shapiro, FG Mihm, PS Satoh, JA Collins, TA Raffin: Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J Clin Invest77 (1986) 1812Search in Google Scholar

51 Takafuji S, K Tadokoro, K Ito, CA Dahinden: Degranulation from human eosinophils stimulated with C3a and C5a. Int Arch Allergy Immunol104Suppl 1 (1994) 27Search in Google Scholar

52 Thomson AJ, JF Telfer, A Young, S Campbell, CJ Stewart, IT Cameron, IA Greer, JE Norman: Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. Hum Reprod14 (1999) 229Search in Google Scholar

53 Vogt W: Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes. Immunobiology195 (1996) 33410.1016/S0171-2985(96)80050-7Search in Google Scholar

54 Vogt W: Cleavage of the fifth component of complement and generation of a functionally active C5b6-like complex by human leukocyte elastase. Immunobiology201 (2000) 47010.1016/S0171-2985(00)80099-6Search in Google Scholar

55 Volanakis JE: Overview of the Complement System. In: Volanakis JE, Frank MM: The Human Complement System in Health and Disease. Marcel Dekker, Inc., New York 199810.1201/9780367800772Search in Google Scholar

56 Walport MJ: Complement. First of two parts. N Engl J Med344 (2001) 105810.1056/NEJM200104053441406Search in Google Scholar PubMed

57 Ward PA: The dark side of C5a in sepsis. Nat Rev Immunol4 (2004) 13310.1038/nri1269Search in Google Scholar PubMed

58 Ward PA, JH Hill: C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J Immunol104 (1970) 535Search in Google Scholar

59 Woodruff TM, TV Arumugam, IA Shiels, RC Reid, DP Fairlie, SM Taylor: Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats. J Surg Res116 (2004) 81Search in Google Scholar

60 Wymann MP, P Kernen, DA Deranleau, M Baggiolini: Respiratory burst oscillations in human neutrophils and their correlation with fluctuations in apparent cell shape. J Biol Chem264 (1989) 15829Search in Google Scholar

Published Online: 2005-08-10
Published in Print: 2005-07-01

© Walter de Gruyter

Downloaded on 23.4.2024 from https://www.degruyter.com/document/doi/10.1515/JPM.2005.051/html
Scroll to top button